Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Non-cash Items (2023 - 2025)

Ekso Bionics Holdings has reported Non-cash Items over the past 3 years, most recently at $11000.0 for Q2 2025.

  • On a quarterly basis, Non-cash Items changed N/A to $11000.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $11000.0, a N/A change, with the full-year FY2023 number at $251000.0, changed N/A from a year prior.
  • Non-cash Items reached $11000.0 in Q2 2025 per EKSO's latest filing, down from $196000.0 in the prior quarter.
  • The five-year high for Non-cash Items was $251000.0 in Q4 2023, with the low at $8000.0 in Q3 2023.
  • The 3-year median for Non-cash Items is $21000.0 (2023), against an average of $97400.0.